Page last updated: 2024-09-05

organophosphonates and Atrophy

organophosphonates has been researched along with Atrophy in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (25.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chialant, D; Damji, KF; Hodge, WG; Wang, L	1
Berke, GS; Bhuta, SM; Chhetri, DK; Hart, SD; Jahan-Parwar, B; Shapiro, NL	1
Borgonovo, S; Brambilla, P; Cafarelli, L; Giacomet, V; Mora, S; Viganò, A; Zamproni, I; Zuccotti, G	1
Cabanela, ME; Jowsey, J	1

Trials

1 trial(s) available for organophosphonates and Atrophy

Article	Year
Normalization of fat accrual in lipoatrophic, HIV-infected children switched from stavudine to tenofovir and from protease inhibitor to efavirenz. Antiviral therapy, 2007, Volume: 12, Issue:3 Topics: Absorptiometry, Photon; Adenine; Adolescent; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atrophy; Benzoxazines; Body Composition; CD4 Lymphocyte Count; Child; Child, Preschool; Cyclopropanes; Female; HIV Protease Inhibitors; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Italy; Male; Organophosphonates; Prospective Studies; Protease Inhibitors; Stavudine; Tenofovir; Time Factors; Treatment Outcome; Viral Load	2007

Article

Year

Normalization of fat accrual in lipoatrophic, HIV-infected children switched from stavudine to tenofovir and from protease inhibitor to efavirenz.

Antiviral therapy, 2007, Volume: 12, Issue:3

Topics: Absorptiometry, Photon; Adenine; Adolescent; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atrophy; Benzoxazines; Body Composition; CD4 Lymphocyte Count; Child; Child, Preschool; Cyclopropanes; Female; HIV Protease Inhibitors; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Italy; Male; Organophosphonates; Prospective Studies; Protease Inhibitors; Stavudine; Tenofovir; Time Factors; Treatment Outcome; Viral Load

2007

Other Studies

3 other study(ies) available for organophosphonates and Atrophy

Article	Year
Hypotony after intravenous cidofovir therapy for the treatment of cytomegalovirus retinitis. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2002, Volume: 37, Issue:7 Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Atrophy; Child; Cidofovir; Ciliary Body; Cytomegalovirus Retinitis; Cytosine; Humans; Infusions, Intravenous; Intraocular Pressure; Male; Ocular Hypotension; Organophosphonates; Organophosphorus Compounds; Ultrasonography	2002
Local and systemic effects of intralaryngeal injection of cidofovir in a canine model. The Laryngoscope, 2003, Volume: 113, Issue:11 Topics: Animals; Antiviral Agents; Atrophy; Blood Urea Nitrogen; Cidofovir; Creatinine; Cytosine; Dogs; Dose-Response Relationship, Drug; Injections, Intramuscular; Kidney; Laryngeal Edema; Laryngeal Muscles; Larynx; Leukocytes; Necrosis; Organophosphonates; Organophosphorus Compounds; Vocal Cords	2003
The effects of phosphonates on experimental osteoporosis. Calcified tissue research, 1971, Volume: 8, Issue:2 Topics: Animals; Atrophy; Bone and Bones; Bone Resorption; Cortisone; Male; Organophosphonates; Osteoporosis; Rats	1971